<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01841645</url>
  </required_header>
  <id_info>
    <org_study_id>AGT2013</org_study_id>
    <nct_id>NCT01841645</nct_id>
  </id_info>
  <brief_title>CLA Metabolism and Effects on Human Health</brief_title>
  <official_title>Conjugated Linoleic Acid (CLA) Depletion-repletion: Metabolism and Bioactivity in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alexandre Guedes Torres</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rio de Janeiro State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidade Federal do Rio de Janeiro</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to investigate the effects of Conjugated Linoleic Acid (CLA) from&#xD;
      dairy products on fatty acid metabolism and human health. A CLA depletion-repletion study was&#xD;
      carried out with healthy volunteers. CLA depletion was achieved through an eight-week dairy&#xD;
      fat restriction, followed by an eight-week repletion period consisting of intake of a butter&#xD;
      naturally enriched with CLA. Changes in body composition, fasting glucose and insulin,&#xD;
      inflammatory mediators, cell membranes' stability, plasma lipid levels and fatty acid&#xD;
      composition of lipid classes are evaluated after depletion and repletion phases.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After collecting baseline blood samples, CLA-depletion phase started with dietary&#xD;
      orientation, by a registered dietitian, to the study subjects (n=29) to exclude from their&#xD;
      diets any type of dairy fat for the following 8 weeks. Blood samples were taken at the end of&#xD;
      CLA-depletion, and CLA-repletion phase was initiated by dietitians' instructions: volunteers&#xD;
      returned to their regular diets, and additionally consumed a CLA-enriched butter for another&#xD;
      8-week period. Blood samples were taken at the end of the CLA-repletion phase. The effects of&#xD;
      CLA on the following parameters were evaluated: inflammatory mediators; fatty acid&#xD;
      composition of erythrocytes, plasma phospholipids and cholesterol esters; body composition;&#xD;
      clinical factors associated with the metabolic syndrome and indicators of cell membranes'&#xD;
      stability.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fatty acid metabolism and inflammatory mediators were accompanied during a CLA depletion-repletion dietary intervention</measure>
    <time_frame>16 weeks</time_frame>
    <description>Changes in body composition, fasting glucose and insulin, inflammatory mediators, cell membrane stability, plasma lipid levels and fatty acid composition of lipid classes were evaluated before and after depletion and repletion phases.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">29</enrollment>
  <condition>Dietary Modification</condition>
  <condition>Inflammation</condition>
  <condition>Body Composition, Beneficial</condition>
  <arm_group>
    <arm_group_label>CLA depletion-repletion</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>CLA depletion-repletion</intervention_name>
    <arm_group_label>CLA depletion-repletion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy volunteers;&#xD;
&#xD;
          -  20 to 40 years;&#xD;
&#xD;
          -  BMI between 18.0 and 29.9 kg/m2.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Use of dietary supplements;&#xD;
&#xD;
          -  Smoker;&#xD;
&#xD;
          -  Alcoholic;&#xD;
&#xD;
          -  Under medication;&#xD;
&#xD;
          -  History of chronic disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexandre G Torres, DSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidade Federal do Rio de Janeiro</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Federal University of Rio de Janeiro</name>
      <address>
        <city>Rio de Janeiro</city>
        <zip>21941-909</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <study_first_submitted>April 17, 2013</study_first_submitted>
  <study_first_submitted_qc>April 23, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 26, 2013</study_first_posted>
  <last_update_submitted>May 2, 2013</last_update_submitted>
  <last_update_submitted_qc>May 2, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 3, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Federal do Rio de Janeiro</investigator_affiliation>
    <investigator_full_name>Alexandre Guedes Torres</investigator_full_name>
    <investigator_title>Professor Alexandre Guedes Torres</investigator_title>
  </responsible_party>
  <keyword>CLA-enriched butter</keyword>
  <keyword>CLA metabolism</keyword>
  <keyword>inflammation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

